Applied Clinical Trials Trends / Having trouble viewing this e-mail? Click Here

In this ISSUE

Finally, Standardized KPIs are Front and Center

Rare Diseases: Meeting the Unique Challenges of Orphan Drug Development

Interventional vs. Non-interventional Study Classification in the EU: Considerations on the Impact of Direct-to-Patient Contacts

Advertisement
Clinical Trial Future
The Future of Clinical Trial Modernization: What's to Come in 2018
2017 has been an exciting year for the clinical trials industry on many fronts, driven by new methods, regulation, and technology, but what is to come in 2018?
... /Read more/
Advertisement
Research Reveals a Need for Evolution in Randomization and Trial Supply Management (RTSM) Technology
Live Webcast: Wednesday, January 17 at 11am EST
Register now
Advertisement
The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT
Register now

Calendar
/ Clinical Data Disclosure and Transparency 1/30-1/31 /
/ EFGCP Annual Conference 2018 2/20-2/21 /
/ Clinical Trial Budgeting & Forecasting 2/22 /
Digital Health
Get Ready for mHealth to Revolutionize the Device Market
Mobile health devices are poised to transform medical care—and with it the medical device market.
... /Read more/
Advertisement
The Clinical Trial of the Future is Here - Now: Understand how technology is transforming clinical development - now and in the future
On Demand
Learn more
Metabolomics
Metabolomics: Improving the Route from Early Drug Discovery through Clinical Development
Metabolomics can make a positive impact from early drug discovery through clinical development and beyond.
... /Read more/
mHEALTH
FDA Releases New Digital Health Draft Guidance Documents
In this interview, Austin Speier, VP of Emerging Technologies at Precision for Medicine, will elaborate on these draft guidance documents.
... /Read more/
Trial Management
Positive Changes for Clinical Trials in Ukraine
The Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.
... /Read more/

Ask the editor
Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com
Advertise
Todd Baker
Group Publisher
todd.baker@ubm.com

website / blog / advertise / subscribe